[1] Seder CW, Hartojo W, Lin L, et al.INHBA overexpression promotes cell proliferation and may be epigenetically regulated in e-sophageal adenocarcinoma[J]. J Thorac Oncol, 2009, 4(4): 455-462.
[2] Wang Q, Wen YG, Li DP, et al. Upregulated INHBA expression is associated with poor survival in gastric cancer[J]. Med On-col, 2012, 29(1): 77-83.
[3] Seder CW, Hartojo W, Lin L, et al. INHBA overexpression promotes cell proliferation and may be epigenetically regulated in esophageal adenocarcinoma[J]. J Thorac Oncol, 2009, 4(4): 455-462.
[4] Seder CW, Hartojo W, Lin L, et al. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma[J]. Neoplasia, 2009, 11(4): 388-396.
[5] Wang Q, Wen YG, Li DP, et al. Upregulated INHBA expression is associated with poor survival in gastric cancer[J]. MedOncol, 2012, 29(1): 77-83.
[6] Okano M, Yamamoto H, Ohkuma H, et al. Significance of INHBA expression in human colorectal cancer[J]. Oncol Rep, 2013, 30(6): 2903-2908.
[7] 周 薇, 毕嘉欣, 冶亚平. INHBA 基因表达上调与左、右半结肠癌临床病理特征及预后的相关性[J]. 临床与实验病理学杂志, 2018, 34(9): 953-957.
[8] Hou T, Zhou L, Wang L, et al. CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway[J]. Oncotarget, 2017, 8(54): 93001-93013.
[9] Yu Y, Walia V, Elble RC. Loss of CLCA4 promotes epithelial-to-mesenchymal transition in breast cancer cells[J]. PLoS One, 2013, 8(12): e83943. |
